Lonza Group AG
LONN
Ранг среди акций
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Цена акции
$764.04
Рыночная капитализация
$53.36B
Изменение (1 день)
0.96%
Изменение (1 год)
8.59%
Страна
CH
Торговля Lonza Group AG (LONN)
Категория
Healthcare
История дроблений акций Lonza Group AG (LONN)
Акции Lonza Group AG (символ: LONN) прошли через 0 дроблений.
Последнее дробление произошло Oct 22, 2026.
Одна акция LONN, купленная до Oct 22, 2026, сейчас соответствует 0 акциям LONN.
Последнее дробление произошло Oct 22, 2026.
Одна акция LONN, купленная до Oct 22, 2026, сейчас соответствует 0 акциям LONN.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
